World's Best Scientists 2026 revealed!
Richard M. W. Hoetelmans

Richard M. W. Hoetelmans

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
8237
World Ranking
15830
National Ranking
6579

Richard M. W. Hoetelmans publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Richard M. W. Hoetelmans sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 150 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Richard M. W. Hoetelmans D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Richard M. W. Hoetelmans sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Richard M. W. Hoetelmans is affiliated with Tibotec in the United States and has contributed to the field of Medicine, with a primary focus on Infectious Diseases. Their work encompasses multiple subfields including Epidemiology, Public Health, Environmental and Occupational Health, Virology, and Psychiatry and Mental Health.

Their research topics cover a range of areas related to viral infections and immunology. Key topics include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • Mosquito-borne diseases and control
  • Malaria Research and Control
  • Viral Infections and Vectors
  • HIV Research and Treatment

Hoetelmans has collaborated frequently with several coauthors, indicating ongoing research partnerships. Frequent coauthors include:

  • Anna Dari
  • Muriel Boulton
  • Juan José Pérez Ruixo
  • Stephen J. Balevic
  • Sam Bozzette

The scientist's work has been published in a variety of journals. Frequent publication venues include:

  • The Journal of Clinical Pharmacology
  • Clinical Infectious Diseases
  • Clinical Pharmacology & Therapeutics
  • AIDS
  • The International Journal of Tuberculosis and Lung Disease

Recent papers authored or coauthored by Hoetelmans cover clinical and pharmacological aspects of infectious diseases and vaccine research. These include:

  • Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers (2023), published in Clinical Infectious Diseases
  • Quantifying Antibody Persistence After a Single Dose of COVID-19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach (2022), published in Clinical Pharmacology & Therapeutics
  • Zidovudine and lamivudine reach higher concentrations in ventricular than in lumbar human cerebrospinal fluid (2020), published in AIDS
  • Infliximab Concentrations in Participants with Moderate to Severe COVID-19 (2023), published in The Journal of Clinical Pharmacology
  • Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates (2023), published in Journal of Pharmacology and Experimental Therapeutics

Best Publications

  • Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

    Pythia T. Nieuwkerk;Mirjam A. G. Sprangers;David M. Burger;Richard M. W. Hoetelmans

  • High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals.

    Agnes I. Veldkamp;Gerrit J. Weverling;Joep M. A. Lange;Julio S. G. Montaner

  • Antiretroviral drugs and the central nervous system

    Roelien H. Enting;Richard M.w. Hoetelmans;Joep M.a. Lange;David M. Burger

  • Therapeutic drug monitoring in HIV infection: current status and future directions.

    David J. Back;Giorgio Gatti;Courtney Fletcher;Rodolphe Garaffo

  • Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.

    Norbert A Foudraine;Richard Mw Hoetelmans;Joep Ma Lange;Frank de Wolf

  • Drug interaction between St John's wort and nevirapine

    M M de Maat;R M Hoetelmans;E C van Gorp

  • Darunavir: pharmacokinetics and drug interactions.

    David Back;Vanitha Sekar;Richard M W Hoetelmans

  • P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir.

    Maarten T. Huisman;Johan W. Smit;Hugh R. Wiltshire;Richard M. W. Hoetelmans

  • Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy.

    David M Burger;Richard Mw Hoetelmans;Patricia Wh Hugen;Jan W Mulder

  • The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.

    Rolf P. G. van Heeswijk;Agnes I. Veldkamp;Jan W. Mulder;Pieter L. Meenhorst

  • The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

    R. M. W. Hoetelmans;M. H. E. Reijers;G. J. Weverling;R. W. Ten Kate

  • Short-term antiviral activity of TMC278--a novel NNRTI--in treatment-naive HIV-1-infected subjects.

    Frank Goebel;Alexy Yakovlev;Anton L Pozniak;Elena Vinogradova

  • Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma

    Andrea Antinori;Carlo Federico Perno;Maria Letizia Giancola;Federica Forbici

  • Clinical pharmacokinetics and pharmacodynamics of etravirine.

    Monika Schöller-Gyüre;Thomas N. Kakuda;Araz Raoof;Goedele De Smedt

  • Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy

    Gerrit J. Weverling;Joep M.A. Lange;Suzanne Jurriaans;Jan M. Prins

  • Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers.

    Monika Schöller-Gyüre;Thomas N Kakuda;Vanitha Sekar;Brian Woodfall

  • Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection

    R.P.G van Heeswijk;R.M.W Hoetelmans;R Harms;P.L Meenhorst

  • The effect of different meal types on the pharmacokinetics of darunavir (TMC114)/ritonavir in HIV-negative healthy volunteers.

    Vanitha Sekar;Dries Kestens;Sabrina Spinosa-Guzman;Martine De Pauw

  • Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir.

    R. M. E. Van Praag;G. J. Weverling;P. Portegies;S. Jurriaans

  • Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir

    R.M.W. Hoetelmans;P.L. Meenhorst;J.W. Mulder;D.M. Burger

Frequent Co-Authors

Jos H. Beijnen
Jos H. Beijnen Utrecht University
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
David M. Burger
David M. Burger Radboud University
David A. Cooper
David A. Cooper University of New South Wales
Anton Pozniak
Anton Pozniak London School of Hygiene & Tropical Medicine
Jan M. Prins
Jan M. Prins University of Amsterdam
Suzanne Jurriaans
Suzanne Jurriaans University of Amsterdam
Sven A. Danner
Sven A. Danner University of Amsterdam
Peter Reiss
Peter Reiss University of Amsterdam
Jan Mulder
Jan Mulder Norwegian University of Life Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Biology and Biochemistry often consider a range of related online degrees and careers. Many choose paths in healthcare or wellness, where scientific backgrounds are in high demand. An online nutrition degree can prepare graduates for roles as dietitians, nutritionists, or wellness coaches—fields strongly connected to biochemistry and human health.

Registered nurses seeking career advancement can enroll in the easiest rn to bsn program, adding clinical expertise and leadership skills that can broaden job prospects. Professionals eager to move into management may pursue a fast online master's in healthcare management, which opens doors to administrative and policy-driven roles.

Likewise, the demand for mental health practitioners is rising. The fastest pmhnp program offers a quick route to becoming a Psychiatric Mental Health Nurse Practitioner, combining a strong science foundation with specialized mental health care.

Best Scientists Citing Richard M. W. Hoetelmans

Trending Scientists

Recently Published Articles